Clinical Trial Update: Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Gosogliptin as monotherapy and with metformin versus Vildagliptin as monotherapy and with metformin in drug-naive Type 2 diabetes patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Gosogliptin (gosogliptin)
• Vildagliptin (vildagliptin)
• metformin (metformin)

Snippet

Sponsor: SatRx LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED